ReviewCancers2025

Real-World Insights into the Impact of Durvalumab on Stage III Unresectable Non-Small Cell Lung Cancer-A Narrative Review.

Giorgio Facheris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.